Radiofrequency ablation (RFA) demonstrates a 99.81% volume reduction rate with minimal complications in treating low-risk papillary thyroid microcarcinomas. Over 46.59 months follow-up, only 69 patients experienced local recurrence, positioning RFA as a compelling alternative to surgery and active surveillance. Notably, retreatment rates were significantly lower post-RFA, highlighting its effectiveness as a long-term treatment option with enduring results.
Review by Xu X, Peng Y and Han G in Eur J Surg Oncol
Copyright © 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.